Remove Marijuana from the Controlled Substances Act: Support H.R. 1227, the Ending Federal Marijuana Prohibition Act of 2017

Even though 31 states have legalized medical marijuana and over 60 percent of Americans support legalization, marijuana is still
listed under Schedule 1 of the Controlled Substances Act. Enforcing federal prohibition of marijuana will only serve to increase incarcerations, prevent invaluable research into its medicinal benefits, and create financial barriers for businesses.

Read More

STAFF ROUNDTABLE: World Psoriasis Day

On October 29th, we will commemorate World Psoriasis Day, which recognizes the impact of psoriasis and psoriatic arthritis, the voices of those affected by these diseases, and the need to develop a cure.

Read More

Cosponsor the Palestinian Authority Educational Curriculum Transparency Act

We urge you to cosponsor the Palestinian Authority Educational Curriculum Transparency Act (H.R. 6034), bipartisan legislation we introduced to require the U.S. Secretary of State to regularly review and report to Congress on the content of educational materials
used by the Palestinian Authority (PA) and the United Nations Relief and Works Agency for Palestine Refugees in the Near East (UNRWA). This legislation follows the release of the Palestinian Authority’s reformed curriculums for grades one through eleven.

Read More

DEADLINE EXTENDED: Urge CMS to Protect Revascularization Services Critical to Preventing Amputations in Our Nation’s Elderly Patients

Please join us in sending a bipartisan letter to the Centers for Medicare & Medicaid Services (CMS) urging the agency to protect access to vital revascularization services integral to the effort of reducing amputations in Medicare patients with peripheral
artery disease (PAD).  The 2019 Physician Fee Schedule (PFS) Proposed Rule is proposing to cut reimbursement for revascularization by up to 30% or more for critical revascularization codes (37225 – 37231, among others).  These cuts stem from CMS’ proposal
to update equipment and supply pricing data in the Medicare Physician Fee Schedule database.  We have concerns with the accuracy of this data for revascularization codes
as they have no pricing data at all in the CMS database. 

Read More

Over 170 Cosponsors – Support the Bipartisan Preventing Maternal Deaths Act

In September 2016, a
Journal of Obstetrics and Gynecology study highlighted an alarming trend – unlike in almost any other industrialized country, maternal deaths in the United States are on the rise. The maternal mortality rate — maternal deaths per 100,000 live births
— increased to 35.8 in 2014, up from 17.7 in 2000. The United States is ranked 47th globally for its maternal mortality rate.

Read More